EP Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
EP Wealth Advisors's DGX Position: Q2 2026 in Review
EP Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 1% in Q2 2026, selling an estimated $7.07K and leaving 3,498 shares worth $741K. The position accounts for ﹤0.01% of the portfolio, ranked #861.
EP Wealth Advisors first reported a position in DGX in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.41M in Q1 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- EP Wealth Advisors held 3,498 shares of Quest Diagnostics worth $741K as of Q2 2026.
- EP Wealth Advisors sold 36 Quest Diagnostics shares in Q2 2026, an estimated $7.07K.
- Quest Diagnostics made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #861 holding.
- EP Wealth Advisors first reported a position in Quest Diagnostics in Q1 2021 and has held it in 19 quarters since.
- EP Wealth Advisors's Quest Diagnostics position peaked at $2.41M in Q1 2021.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.